Corcept Therapeutics | CORT - Umlaufvermögen

Aktienkurs
52.95
Täglich Wechseln
1.62 3.16%
Monatlich
27.01%
Jährlich
-24.85%
Q2 Prognose
50.35




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alaunos Therapeutics USD 1.99M 697K 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Ardelyx USD 381.87M 447K 2026-03
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Esperion Therapeutics USD 462.57M 102.11M 2025-12
J&J USD 59.17B 3.55B 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Novartis USD 30.46B 2.26B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
TG Therapeutics USD 630.76M 31M 2025-12